- Report
- March 2021
- 45 Pages
Global
From €2203EUR$2,495USD£1,910GBP
- Report
- December 2019
- 104 Pages
Asia Pacific
From €7942EUR$8,995USD£6,884GBP
- Report
- October 2019
- 157 Pages
Global
From €13240EUR$14,995USD£11,477GBP
- Report
- January 2021
- 148 Pages
China, Global
From €3000EUR$3,640USD£2,691GBP
- Report
- April 2024
- 140 Pages
Global
From €4370EUR$4,949USD£3,788GBP
- Report
- May 2023
- 147 Pages
Global
From €4370EUR$4,949USD£3,788GBP
- Report
- July 2024
- 157 Pages
Global
From €3753EUR$4,250USD£3,253GBP
- Report
- July 2024
- 158 Pages
Global
From €3753EUR$4,250USD£3,253GBP
- Report
- August 2024
- 224 Pages
Global
From €4410EUR$4,995USD£3,823GBP
- Report
- February 2024
- 177 Pages
Global
€4410EUR$4,995USD£3,823GBP
- Report
- January 2024
- 106 Pages
Global
€4410EUR$4,995USD£3,823GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €530EUR$600USD£459GBP
- Report
- August 2023
- 1300 Pages
Global
From €7858EUR$8,900USD£6,812GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4327EUR$4,900USD£3,750GBP
- Report
- August 2023
- 51 Pages
Brazil
From €530EUR$600USD£459GBP
- Report
- August 2023
- 51 Pages
Australia
From €530EUR$600USD£459GBP
- Report
- August 2023
- 51 Pages
Japan
From €530EUR$600USD£459GBP
- Report
- August 2023
- 51 Pages
United States
From €530EUR$600USD£459GBP
- Report
- August 2023
- 51 Pages
Argentina
From €530EUR$600USD£459GBP
- Report
- August 2023
- 51 Pages
Mexico
From €530EUR$600USD£459GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more